Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2  (08-2017)

Period of time： 2017年2期

Publisher： Bentham Science Publishers

Founded in： 2014

Total resources： 6

ISSN： 2212-7070

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2

Menu

Meet Our Editorial Board Member

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 79-79

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Editorial (Thematic Issue: Cystic Fibrosis: Pathophysiology and Drug Discovery)

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 80-81

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Macrophage Dysfunctions in Cystic Fibrosis Pulmonary Disease: Implications in Inflammation and Chronic Infections

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 82-91

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Biomarkers of Inflammation and Remodelling in Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 92-108

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Inhaled Hypertonic Saline as a Therapeutic Strategy to Dampen Inflammation in Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 109-116

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 117-129

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Natural Substances in the Treatment of Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 130-139

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Novel Personalised Drugs for Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 140-147

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Topical Application of In Vitro Transcribed mRNA to the Airways as a Novel Gene Therapy Approach for the Treatment of Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 148-161

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells

Clinical Immunology, Endocrine & Metabolic Drugs,volume 3,issue 2 , Vol. 3, Iss. 2, 2017-08 , pp. 162-168

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 11 item(s)